Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Low-Density-Lipoprotein-cholesterol Level”

206 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 206 results

Post-approval studies (Phase 4)Study completedNCT00079638
What this trial is testing

Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELL

Who this might be right for
DyslipidemiaCoronary Heart DiseaseAtherosclerosis+2 more
Kos Pharmaceuticals 300
Not applicableLooking for participantsNCT07685639
What this trial is testing

Electronic Health Record Augmented LDL-Cholesterol Optimization and Control Via Active Lipid Engagement (EHR-LOCALE): A Quality Improvement Implementation Study

Who this might be right for
ACS (Acute Coronary Syndrome)HyperlipidemiaDyslipidemia+1 more
University of Alberta 2,000
Not applicableEnded earlyNCT05629767
What this trial is testing

Tracking of Lipid Lowering Therapy in Jordan

Who this might be right for
DyslipidemiasAtherosclerotic Cardiovascular Disease
Jordan Collaborating Cardiology Group 1,000
Post-approval studies (Phase 4)Study completedNCT00298909
What this trial is testing

Exercise Versus Niacin in Patients With Coronary Artery Disease (CAD) and Low High-Density Lipoproteins (HDL)

Who this might be right for
Coronary DiseaseHypolipoproteinemia
University of Leipzig 48
Post-approval studies (Phase 4)Study completedNCT00442845
What this trial is testing

Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST)

Who this might be right for
Coronary ArteriosclerosisDiabetes Mellitus, Type 2Cerebrovascular Accident+2 more
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 2,080
Not applicableStudy completedNCT00931320
What this trial is testing

Investigation Into the RAtio of LDL-CHolestEroL to HDL-Cholesterol Improvement After Statin Treatment in Korean Patients

Who this might be right for
Dyslipidemias
AstraZeneca 3,000
Not applicableStudy completedNCT02993120
What this trial is testing

Getting to an Improved Understanding of Low-Density Lipoprotein Cholesterol and Dyslipidemia Management (GOULD) a Registry of High Cardiovascular Risk Subjects in the United States

Who this might be right for
Medical Conditions to be StudiedDyslipidemiaASCVD Management
Amgen 5,006
Testing effectiveness (Phase 2)Study completedNCT00529542
What this trial is testing

A Trial of Lipitor (Atorvastatin) for the Treatment of Polycystic Ovary Syndrome (PCOS) in Women With Elevated Low-density Lipoprotein (LDL) Cholesterol

Who this might be right for
Polycystic Ovary Syndrome
Milton S. Hershey Medical Center 20
Not applicableStudy completedNCT07615166
What this trial is testing

Low-Density Lipoprotein Cholesterol Reduction With Alirocumab 150 mg Versus Inclisiran in Individuals Initiating Therapy in Routine Clinical Practice

Who this might be right for
Atherosclerotic Cardiovascular Disease
Sanofi 996
Large-scale testing (Phase 3)Study completedNCT00092612
What this trial is testing

Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-802)(COMPLETED)

Who this might be right for
HypercholesterolemiaCoronary Disease
Organon and Co 372
Large-scale testing (Phase 3)Active Not RecruitingNCT04765657
What this trial is testing

Study of Efficacy and Safety of Inclisiran in Asian Participants With Atherosclerotic Cardiovascular Disease (ASCVD) or ASCVD High Risk and Elevated Low Density Lipoprotein Cholesterol (LDL-C)

Who this might be right for
Hypercholesterolemia
Novartis Pharmaceuticals 345
Post-approval studies (Phase 4)Looking for participantsNCT07839741
What this trial is testing

LDL Cholesterol Reduction Following Ezetimibe Initiation

Who this might be right for
Atherosclerotic Cardiovascular Disease (ASCVD)Cardiovascular RiskLDL Cholesterol
Universidade do Porto 100
Not applicableUnknownNCT01600313
What this trial is testing

Effect of Low Calorie Diet With Rice Bran Oil on Cardiovascular Risk Factors in Hyperlipidemic Patients

Who this might be right for
Hyperlipidemias
Qazvin University Of Medical Sciences 50
Testing effectiveness (Phase 2)Study completedNCT06173570
What this trial is testing

Assess the Efficacy, Safety and Tolerability of Different Doses of AZD0780 in Patients With Dyslipidemia

Who this might be right for
Dyslipidemia
AstraZeneca 428
Very early researchNot Yet RecruitingNCT06293729
What this trial is testing

Safety and Efficacy Study of NGGT006 in Refractory Hypercholesterolemia Patients

Who this might be right for
Refractory HypercholesterolemiaFamilial Hypercholesterolemia
Suzhou Municipal Hospital 9
Not applicableUnknownNCT05188430
What this trial is testing

Metabolic Effect of an Innovative Chitosan Formulation

Who this might be right for
HypercholesterolemiaOverweight and Obesity
University of Bologna 60
Post-approval studies (Phase 4)Study completedNCT00249938
What this trial is testing

Evaluation of Combination Cholesterol Treatments in Patients With High Cholesterol.

Who this might be right for
HyperlipidemiaDyslipidemia
University of Colorado, Denver 60
Early research (Phase 1)Study completedNCT02508896
What this trial is testing

Study Assessing Safety, Immunogenicity and LDLc -Lowering Activity of 2 PCSK9 Targeting AFFITOPE Vaccines in Healthy Subjects

Who this might be right for
Hypercholesterolemia
Affiris AG 72
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07391722
What this trial is testing

DNV001 Injection in Patients With Hypercholesterolemia

Who this might be right for
Primary Hypercholesterolemia
Hangzhou Dinovate Biotech Co., Ltd 120
Testing effectiveness (Phase 2)Study completedNCT03718286
What this trial is testing

Effects of Acute, Rapid Lowering of LDL Cholesterol With Alirocumab in Patients With STEMI Undergoing Primary PCI

Who this might be right for
ST Elevation Myocardial InfarctionAcute Coronary SyndromeHypercholesterolemia+3 more
Population Health Research Institute 97
Next Page